| Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma (NCT00089115) | Favrille | 2004-07-01 |
| Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma (NCT00070304) | Children's Oncology Group | 2004-07-01 |
| Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma (NCT00182637) | Jonsson Comprehensive Cancer Center | 2004-07-01 |
| Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization. (NCT00299780) | Massachusetts General Hospital | 2004-07-01 |
| Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular Lymphoma (NCT00290511) | M.D. Anderson Cancer Center | 2004-06-29 |
| Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma (NCT00227695) | Swiss Cancer Institute | 2004-06-08 |
| Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer (NCT00134017) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-06-01 |
| 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma (NCT00088868) | National Institutes of Health Clinical Center (CC) | 2004-06-01 |
| Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma (NCT00182650) | City of Hope Medical Center | 2004-06-01 |
| Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED) (NCT00086125) | Merck Sharp & Dohme LLC | 2004-06-01 |
| Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy (NCT01078350) | Stanford University | 2004-05-01 |
| Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma (NCT00086801) | Alliance for Clinical Trials in Oncology | 2004-05-01 |
| Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation (NCT00087009) | Memorial Sloan Kettering Cancer Center | 2004-05-01 |
| Rituximab in Treating Patients With Refractory or Relapsed Primary CNS Lymphoma (NCT00072449) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-05-01 |
| G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders (NCT00253552) | OHSU Knight Cancer Institute | 2004-05-01 |
| Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma (NCT00470405) | Vanderbilt-Ingram Cancer Center | 2004-05-01 |
| Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma (NCT00110149) | Beth Israel Deaconess Medical Center | 2004-05-01 |
| Pegfilgrastim and Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Aggressive B-Cell Non-Hodgkin Lymphoma (NCT00726700) | Universität des Saarlandes | 2004-05-01 |
| Anti-Tac(Fv)-PE38 (LMB-2) to Treat Cutaneous T-Cell Lymphomas (NCT00080535) | National Cancer Institute (NCI) | 2004-04-30 |
| LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma (NCT00085150) | National Cancer Institute (NCI) | 2004-04-01 |
| Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer (NCT00498719) | M.D. Anderson Cancer Center | 2004-04-01 |
| Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies (NCT00795132) | University of Utah | 2004-04-01 |
| Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas (NCT00085904) | GlaxoSmithKline | 2004-04-01 |
| Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease (NCT00521430) | Asan Medical Center | 2004-04-01 |
| Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma (NCT00062114) | Alliance for Clinical Trials in Oncology | 2004-04-01 |
| Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL) (NCT00500240) | M.D. Anderson Cancer Center | 2004-04-01 |
| R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma (NCT00450801) | University of Miami | 2004-04-01 |
| Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma (NCT00255723) | Memorial Sloan Kettering Cancer Center | 2004-04-01 |
| Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma (NCT00317408) | European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma | 2004-04-01 |
| Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation (NCT00080873) | Children's Oncology Group | 2004-04-01 |
| Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor (NCT00304720) | Colorado Blood Cancer Institute | 2004-03-01 |
| Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma (NCT00244946) | Barbara Ann Karmanos Cancer Institute | 2004-03-01 |
| Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia (NCT00324779) | University Hospital Erlangen | 2004-03-01 |
| Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's Lymphoma (NCT00081861) | M.D. Anderson Cancer Center | 2004-03-01 |
| Collecting and Storing Blood Samples From Patients With Cancer (NCT00900120) | University of Medicine and Dentistry of New Jersey | 2004-03-01 |
| Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma (NCT00242996) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-03-01 |
| T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies (NCT00080925) | National Institutes of Health Clinical Center (CC) | 2004-02-01 |
| A Study of Actonel for the Prevention of Bone Loss (NCT00452439) | M.D. Anderson Cancer Center | 2004-02-01 |
| Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant (NCT00238368) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-02-01 |
| Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma (NCT00290667) | German High-Grade Non-Hodgkin's Lymphoma Study Group | 2004-02-01 |
| STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors (NCT00088101) | Synta Pharmaceuticals Corp. | 2004-02-01 |
| S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma (NCT00070018) | SWOG Cancer Research Network | 2004-02-01 |
| Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma (NCT00387023) | M.D. Anderson Cancer Center | 2004-02-01 |
| Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer (NCT00123760) | AHS Cancer Control Alberta | 2004-02-01 |
| Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer (NCT00402935) | Case Comprehensive Cancer Center | 2004-02-01 |
| Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma (NCT00075946) | Eastern Cooperative Oncology Group | 2004-01-23 |
| A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years (NCT00079105) | Newcastle-upon-Tyne Hospitals NHS Trust | 2004-01-01 |
| Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma (NCT00430053) | National Institutes of Health Clinical Center (CC) | 2004-01-01 |
| BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma (NCT00077493) | MedImmune LLC | 2004-01-01 |
| Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma (NCT00079261) | European Organisation for Research and Treatment of Cancer - EORTC | 2004-01-01 |
| Dose Reduction in Thoracic CT (NCT00188461) | University Health Network, Toronto | 2004-01-01 |
| Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia (NCT00081068) | Jonsson Comprehensive Cancer Center | 2004-01-01 |
| G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients (NCT00499343) | M.D. Anderson Cancer Center | 2004-01-01 |
| FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00077194) | National Cancer Institute (NCI) | 2004-01-01 |
| T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases (NCT00589602) | The Cleveland Clinic | 2004-01-01 |
| Study to Test a Computer-assisted Support System to Improve Patient-centered Care and Symptom Relief in Cancer Patients (NCT00709813) | Oslo University Hospital | 2003-12-01 |
| Y 90 Ibritumomab Tiuxetan &Rituximab Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma (NCT00073957) | Beth Israel Deaconess Medical Center | 2003-12-01 |
| Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer (NCT00255684) | University of Rochester | 2003-12-01 |
| Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma (NCT00059839) | Children's Oncology Group | 2003-11-01 |
| Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma (NCT00070447) | National Cancer Institute (NCI) | 2003-11-01 |
| Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma (NCT00070187) | Children's Oncology Group | 2003-11-01 |
| Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides (NCT00074087) | European Organisation for Research and Treatment of Cancer - EORTC | 2003-10-01 |
| Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant (NCT00534118) | Roswell Park Cancer Institute | 2003-10-01 |
| LMP2a-Specific Cytotoxic T-Lymphocytes, Lymphoma (ACDAL) (NCT00082225) | Baylor College of Medicine | 2003-10-01 |
| S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction (NCT00049400) | SWOG Cancer Research Network | 2003-10-01 |
| Lymphoma Follow-up (NCT00744120) | National Institute on Aging (NIA) | 2003-10-01 |
| Dose Augmented Rituximab and ICE for Pts With Primary Refractory and Poor Risk Relapsed Aggressive B-Cell NHL (NCT00588094) | Memorial Sloan Kettering Cancer Center | 2003-10-01 |
| Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma (NCT00506129) | M.D. Anderson Cancer Center | 2003-09-01 |
| Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases (NCT00084695) | Milton S. Hershey Medical Center | 2003-09-01 |
| CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant (NCT00369291) | Masonic Cancer Center, University of Minnesota | 2003-09-01 |
| Dendritic Cell Vaccine in Treating Patients With Indolent B-Cell Lymphoma or Multiple Myeloma (NCT00937183) | Jan Walewski | 2003-09-01 |
| Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma (NCT00416819) | University of California, San Francisco | 2003-09-01 |
| Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma (NCT00290433) | M.D. Anderson Cancer Center | 2003-09-01 |
| Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma (NCT00897923) | Mayo Clinic | 2003-09-01 |
| Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma (NCT01538472) | M.D. Anderson Cancer Center | 2003-09-01 |
| Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (NCT00078949) | NCIC Clinical Trials Group | 2003-08-27 |
| Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer (NCT00248430) | Fred Hutchinson Cancer Center | 2003-08-01 |
| Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer (NCT00070382) | Jonsson Comprehensive Cancer Center | 2003-08-01 |
| Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease (NCT00118326) | Fred Hutchinson Cancer Center | 2003-08-01 |
| Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma (NCT00068250) | Radiation Therapy Oncology Group | 2003-07-01 |
| Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets (NCT00074763) | M.D. Anderson Cancer Center | 2003-07-01 |
| PET Scan in Planning Treatment in Patients Undergoing Combination Chemotherapy For Stage IA or Stage IIA Hodgkin Lymphoma (NCT00943423) | University College, London | 2003-07-01 |
| Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy (NCT00066599) | National Cancer Institute (NCI) | 2003-06-01 |
| Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation (NCT00064311) | National Institutes of Health Clinical Center (CC) | 2003-06-01 |
| Epoetin Alfa in Treating Anemia in Patients With Solid Tumors (NCT00058331) | Alliance for Clinical Trials in Oncology | 2003-06-01 |
| Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma (NCT00090909) | Jonsson Comprehensive Cancer Center | 2003-06-01 |
| Serum Protein Patterns in Participants With Mycosis Fungoides/Cutaneous T-Cell Lymphoma, Psoriasis, or Normal Skin (NCT00066664) | National Institutes of Health Clinical Center (CC) | 2003-06-01 |
| Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies (NCT00068523) | Case Comprehensive Cancer Center | 2003-06-01 |
| Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation (NCT00089037) | Fred Hutchinson Cancer Center | 2003-06-01 |
| Phase I Study of Sequential Cord Blood Transplants (NCT00299767) | Massachusetts General Hospital | 2003-05-01 |
| Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED) (NCT00060645) | Merck Sharp & Dohme LLC | 2003-05-01 |
| Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies (NCT00943293) | University of Chicago | 2003-05-01 |
| Amifostine for Head and Neck Irradiation in Lymphoma (NCT00136474) | Dana-Farber Cancer Institute | 2003-05-01 |
| Bortezomib in Treating Patients With Diffuse Large B-Cell Lymphoma That Is Refractory To Chemotherapy (NCT00066508) | Jonsson Comprehensive Cancer Center | 2003-05-01 |
| Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00062140) | Fred Hutchinson Cancer Center | 2003-04-01 |
| Study of @neWorld: A Virtual Community for Children With Cancer (NCT00070421) | Leap of Faith Technologies | 2003-04-01 |
| Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse (NCT00069966) | Theradex | 2003-04-01 |
| Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Waldenstrom's Macroglobulinemia (NCT00060294) | Jonsson Comprehensive Cancer Center | 2003-04-01 |
| Pegfilgrastim PBPC Mobilization Study (NCT00066092) | Amgen | 2003-04-01 |
| Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma (NCT00631579) | Sanofi | 2003-04-01 |